[EN] HCV PROTEASE INHIBITORS<br/>[FR] INHIBITEURS DE PROTÉASE DU VHC
申请人:TAIGEN BIOTECHNOLOGY CO LTD
公开号:WO2009139792A1
公开(公告)日:2009-11-19
This invention relates to macrocyclic compounds of formula (I) or (II) shown in the specification. These compounds can be used to treat hepatitis C virus infection.
HCV PROTEASE INHIBITORS
申请人:Lin Chu-chung
公开号:US20090286814A1
公开(公告)日:2009-11-19
This invention relates to macrocyclic compounds of formula (I) or (II) shown in the specification. These compounds can be used to treat hepatitis C virus infection.